• In the past six months, MasTec reported solid quarterly results, with its backlog reaching US$20.33 billion and earnings per share rising strongly over the last two years.
• This combination of a growing backlog and faster earnings per share growth suggests MasTec has been converting a healthy project pipeline into higher profitability.
• Now we’ll examine how MasTec’s expanded US$20.33 billion backlog may influence its existing investment narrative and future expectations.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

MasTec Investment Narrative Recap

To own MasTec, you generally need to believe that its large infrastructure backlog will turn into steady revenues and improving profitability without major execution stumbles. The recent jump in backlog to US$20.33 billion reinforces that near term catalyst, but also raises the key risk: if big projects are delayed or cancelled, MasTec’s higher fixed costs and client concentration could weigh on margins rather than support them.

The recent US$700 million delayed draw term loan linked to the Superior Group acquisition is especially relevant here, as it underlines how MasTec is using additional financing to expand its electrical and infrastructure capabilities. That expansion could help support backlog conversion and future earnings if projects progress as planned, but it also adds financial and integration risk at a time when investors are closely watching how MasTec executes on its record pipeline.

Yet while the backlog and earnings growth may look reassuring, investors should also be aware that...

MasTec’s narrative projects $20.3 billion revenue and $880.9 million earnings by 2029.

Uncover how MasTec's forecasts yield a $348.72 fair value, a 3% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already looking for MasTec to reach about US$25.5 billion in revenue and US$1.3 billion in earnings by 2029, which is a far more upbeat story than the consensus narrative. When you compare that to concerns about fossil fuel exposure and project complexity risks, and then layer in a fresh US$20.33 billion backlog, it is clear this new information could shift both the bullish and more cautious views in different ways.

Explore 8 other fair value estimates on MasTec - why the stock might be worth less than half the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your MasTec research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free MasTec research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate MasTec's overall financial health at a glance.

Ready For A Different Approach?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Find 49 companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.